Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Advanced Computer Software Chairman trades in 1m shares

Fri, 01st Nov 2013 16:08

The Chairman of Advanced Computer Software this week sliced off 870,380 pounds-worth of shares from his stake, reducing it to 2.42m, the group announced after the close on Thursday. Michael Jackson disposed of exactly 1m shares in the healthcare and business management software, and said he made the sale for "personal reasons". Jackson, who took up the post of Chairman in 2008, was able to take advantage of the strong rise seen in the group's share price since the start of the year, during which time it has climbed from a low of 68p, to sell at 87.038p a piece.The disposal was made on Wednesday, the same day the company posted a 74% jump in group revenue to £99.1m, driven largely by the acquisition of CSH earlier this year, and a 7% rise in pre-tax profit. The group revealed it was "increasingly confident" of delivering good full year results and said it was in an "excellent" position to take advantage of further acquisition opportunities. Top Director BuysAstraZeneca (AZN) Director name: Mr Pascal SoriotAmount purchased: 23,981 @ 3,330.00p Value: £798,567Puricore (PURI) Director name: Mr Daniel Hegglin Amount purchased: 1,000,000 @ 45.00p Value: £450,000Symphony International Holdings Ltd. (SIHL) Director name: Mr Anil ThadaniAmount purchased: 500,000 @ $0.76 Value: $380,000Berkeley Group Holdings (The) (BKG) Director name: Mr David HowellAmount purchased: 1,200 @ 2,450.00p Value: £29,400Travis Perkins (TPK) Director name: Mr Robert M WalkerAmount purchased: 805 @ 1,845.00p Value: £14,852Arden Partners (ARDN) Director name: Mr Jonathan B KeelingAmount purchased: 25,000 @ 48.50p Value: £12,125NB Global Floating Rate Income Fund Limited Red C Shs GBP (NBCS) Director name: Mr Richard John BatteyAmount purchased: 10,000 @ 100.00p Value: £10,000NB Global Floating Rate Income Fund Limited Red C Shs GBP (NBCS) Director name: Mrs Sandra PlattsAmount purchased: 10,000 @ 100.00p Value: £10,000NB Global Floating Rate Income Fund Limited Red C Shs GBP (NBCS) Director name: Mr William FrewenAmount purchased: 10,000 @ 100.00p Value: £10,000Top Director SellsDotDigital Group (DOTD) Director name: Mr Peter A. SimmondsAmount sold: 2,000,000 @ 21.00p Value: £420,000DotDigital Group (DOTD) Director name: Mr Ian (Tink) TaylorAmount sold: 1,100,000 @ 21.00p Value: £231,000DotDigital Group (DOTD) Director name: Mr Simon C. BirdAmount sold: 1,100,000 @ 21.00p Value: £231,000Jarvis Securities (JIM) Director name: Mr Andrew J GrantAmount sold: 50,000 @ 400.00p Value: £200,000SpaceandPeople (SAL) Director name: Mr Martin KempAmount sold: 75,000 @ 112.25p Value: £84,188Informa (INF) Director name: Mr Peter RigbyAmount sold: 4,000 @ 555.00p Value: £22,200NR

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.